Drugs / samarium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00126230 | Jan 2004 → ? | prostate cancer | Gustave Roussy, Cancer Campus, Grand Paris | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | samarium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00126230 ↗ |